OGN Organon & Co.

NYSE
$13.82

Organon & Co. (OGN) is expected to report earnings on January 29, 2027, before the market open. The consensus earnings estimate is $0.80 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.1% since its last earnings release on October 30, 2026.

Organon Missed Consensus Estimates
Earnings Date
4th Quarter, Dec 2026
Jan 29
Friday · Before Open
Earnings Whisper
-
vs $0.80
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.83

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Organon & Co.

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.